Showing promise in the landscape of weight management treatment, retatrutide represents a distinct method. Beyond many existing medications, retatrutide operates as a twin agonist, concurrently engaging both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) sensors. The concurrent activation encourages multiple bene